loadpatents
name:-0.017402172088623
name:-0.010327100753784
name:-0.00047993659973145
Guile; Simon Patent Filings

Guile; Simon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guile; Simon.The latest application filed is for "trisubstituted triazolopyrimidines for use in platelet aggregation inhibition".

Company Profile
0.9.15
  • Guile; Simon - Hathern GB
  • Guile; Simon - Cheshire GB
  • Guile; Simon - Loughborough GB
  • Guile; Simon - Leics GB
  • Guile; Simon - Leicestershire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Triazolo(4,5-D)pyrimidine compounds
Grant RE46,276 - Hardem , et al. January 17, 2
2017-01-17
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
App 20150152111 - Hardern; David ;   et al.
2015-06-04
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibiton
App 20140296258 - Hardern; David ;   et al.
2014-10-02
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
App 20130109702 - Hardern; David ;   et al.
2013-05-02
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
App 20130072503 - Hardern; David ;   et al.
2013-03-21
Novel compounds
App 20120165348 - Hardern; David ;   et al.
2012-06-28
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
App 20100069408 - Hardern; David ;   et al.
2010-03-18
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
App 20080214812 - Hardern; David ;   et al.
2008-09-04
Substituted [1,2,3]triazolo[4,5-d]pyrimidines
Grant 7,345,047 - Guile , et al. March 18, 2
2008-03-18
Novel Compounds 171
App 20080058309 - Cheshire; David ;   et al.
2008-03-06
Novel compounds
App 20070265282 - Hardern; David ;   et al.
2007-11-15
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
Grant 7,250,419 - Hardern , et al. July 31, 2
2007-07-31
Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds
Grant 7,034,032 - Brown , et al. April 25, 2
2006-04-25
Novel compounds
App 20060025590 - Hardern; David ;   et al.
2006-02-02
Compounds
Grant 6,974,868 - Hardern , et al. December 13, 2
2005-12-13
Novel compounds
App 20050143399 - Guile, Simon ;   et al.
2005-06-30
2,3,4-cyclopentan-2,3,4-triol-1-yl compounds
Grant 6,844,348 - Guile , et al. January 18, 2
2005-01-18
[1,2,3]-triazolo[4,5-d] pyrimidine compounds
Grant 6,713,483 - Guile , et al. March 30, 2
2004-03-30
Novel compounds
App 20040029899 - Guile, Simon ;   et al.
2004-02-12
Novel compounds
App 20040023988 - Brown, Roger ;   et al.
2004-02-05
Novel compounds
App 20030144305 - Hardern, David ;   et al.
2003-07-31
Triazolo(4,5-d)pyrimidine compounds
Grant 6,525,060 - Hardern , et al. February 25, 2
2003-02-25
1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
Grant 6,251,910 - Guile , et al. June 26, 2
2001-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed